Note: Ingredients listed on restricted chemical lists
EC/CAS
50-99-7
Name of the chemical
Glucose C6H12O6
Concentration
N/A
General Information
Revision date
2022-02-17
Product name
ZINACEF (CEFUROXIME INJECTION)
Product Synonyms
ZINACEF FROZEN PREMIX 750MG/50ML * ZINACEF FROZEN PREMIX 1.5G/50ML * ZINACEF
1.2.2. Uses advised against
No other uses are advised
supplier name
GlaxoSmithKline UK
Emergency telephone
VERISK 3E GLOBAL INCIDENT RESPONSE
Icons in SDS
Company Information
company name
GlaxoSmithKline UK
e-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
GHS Information
Signal word
Warning
Section 2
SECTION 2: Hazards identification
result in GHS classification: 2.1 GHS classification of substance or mixture, and national or regional information
Physical hazards
Not classified.
Health hazards
Sensitization, skin Category 1
Environmental hazards
Not classified.
Signal word
Warning
Hazard statements
May cause an allergic skin reaction.
Prevention
Avoid breathing mist/vapours. Contaminated work clothing should not be allowed out of the workplace. Wear protective gloves.
Response
IF ON SKIN Wash with plenty of soap and water. Specific treatment (see instruction on this label). If skin irritation or rash occurs Get medical advice/attention. Wash contaminated clothing before reuse.
Disposal
Dispose of contents/container in accordance with local/regional/national/international regulations. 2.3 Other hazards which do not Caution - Pharmaceutical agent. See section 11 of the SDS for additional information on health result in GHS classification hazards.
Additional information
2.55 % of the mixture consists of component(s) of unknown acute oral toxicity. 4.28 % of the mixture consists of component(s) of unknown acute dermal toxicity.
